When Henny joined Anthony Nolan in 2009, she set out a bold ambition to transform the registry’s ability to meet patient need. Early on, Henny established a far-reaching new strategy that included a radical transformation of Anthony Nolan’s brand and communications. Inspired by the passion and commitment of Anthony Nolan’s staff, Henny works to build on the charity’s rich history and secure it a successful future.
At Anthony Nolan, Henny works with staff at all levels, Trustees and supporters, as well as with external stakeholders, such as government departments. She sees it as her role to deliver our vision, champion our cause, and to inspire people to help our lifesaving work. Henny was named as the Charity Times Charity Principal of the Year in 2013 and has steered the charity to several awards including Charity Times’ Charity of the Year in 2012.
Previously Resources Director at Shelter, the housing charity, Henny draws on 20 years’ experience in the voluntary sector. She is a former Trustee for the Small Charities Coalition and was Chair for Aids and Housing (Health and Housing). She has also been a Trustee for Thames Reach and Shelter Trading.
Henny is a current Board member of World Marrow Donor Association (WMDA) and The Mix.
Chief Engagement & Marketing Officer
Terence joined Anthony Nolan in November 2018 and leads the Engagement division. Terence is responsible for the engagement strategy that will connect more people with our cause and enable them to help our lifesaving work. The division is responsible for developing the voluntary income strategy for the organisation, building awareness of our work, including the brand and communications strategy and overseeing essential growth in the stem cell donor register. The importance of our supporters is critical in our success as an organisation and the Engagement division plays a key role in building meaningful long-term relationships to enable the organisation to save even more lives.
Terence has worked in the not-for-profit sector for over 16 years. Terence built his career at Barnardo’s, Save the Children and most recently at Teach First where he was Director of Development and played a key role in developing and launching Teach First’s new organisational strategy and as part of Save the Children’s leadership team delivering significant growth across the fundraising mix, including launching the multi-million pound Christmas Jumper Day. A committed Institute of Fundraising member, Terence was named one of Fundraising Magazine’s 25 under 35 best young fundraisers in the UK in 2016
Chief Operating Officer
Nic Alderson joined Anthony Nolan in December 2013 and is responsible for the operations of the organisation. This involves the management of the aligned register, the process of finding a match for patients, ensuring our donors are looked after both before and during the donation process, and the cord blood collection programme. Nic is also responsible for the Patient Services team, which provides support and information to patients and families at every stage of the ‘transplant journey’ – from the point they are told they need a transplant, right through to long-term recovery.
Nic is leading the team in Operations and Patient Services to continually improve our practice to ensure we can provide much-needed stem cells for patients in the quickest and most effective way, both in the UK and internationally.
Nic has 20 years' experience in the charity sector, having previously worked at Save the Children, Positively Women, Refugee Council, and Shelter, and joined Anthony Nolan after five years at the NSPCC where she was Director of Planning and Performance and led on the programme management of the delivery of the children's services.
Professor Steven GE Marsh BSc, PhD, ARCS, FRCPath
Chief Bioinformatics & Immunogenetics Officer
Prof. Marsh heads the immunogenetics and bioinformatics research in the Anthony Nolan Research Institute. He is also Professor of Immunogenetics at University College London and Chairman of the World Health Organization (WHO) Nomenclature Committee for Factors of the HLA System, and the WHO/IUIS Nomenclature Committee for Killer-cell Immunoglobulin-like Receptors (KIR). He is currently Honorary President of the British Society for Histocompatibility and Immunogenetics (BSHI) and formerly President of the European Federation for Immunogenetics (EFI), and International HLA and Immunogenetics Workshops. In 2016 he became Editor-in-Chief of the journal HLA (formerly Tissue Antigens).
The aim of his research group is to improve the outcome of haematopoietic stem cell transplantation by understanding genetic differences, particularly the matching of HLA and KIR genes, between patients and donors. This work is undertaken by both bioinformatics and laboratory-based projects. He initiated the IPD-IMGT/HLA and IPD-KIR Databases, which are the worldwide resource for HLA and KIR sequences.
Chief Digital & Information Officer
Danny Attias is responsible for realising Anthony Nolan’s digital technology potential and driving change initiatives in the organisation. Accountable for all aspects of technology strategy and delivery, he is passionate about utilising innovative technology to enrich the lives of all the people who are a part of making Anthony Nolan great.
Danny is an energetic and enthusiastic personality who often presents at technology leadership forums. He has been an early adopter and strong proponent of cloud based services, agile project delivery and the use of analytics to create success.
Having read Chemical Engineering at Loughborough University Danny joined the John Lewis Partnership where he spent 9 fruitful years as a Partner in their Waitrose Division; ultimately taking a leadership role in store technical infrastructure. Most recently Danny held the role of Global CIO at the Grass Roots Group, a leading employee and customer engagement solutions provider, which owns such brands as Cyclescheme, Care-4 and Bonusbonds. He has been a part of the Anthony Nolan team since May 2016.
Chief Financial Officer
Ian joined Anthony Nolan in January 2020 and leads the Finance and Resources Directorate, which includes the Finance, Facilities, Procurement, Legal and Governance teams.
Ian is a fellow of the Chartered Institute of Certified Accountants and holds a BSc (Hons) degree in Chemistry from Nottingham University.
Ian has a wealth of commercial, financial and operational leadership experience in major FTSE 100 companies, charities and SMEs. This included roles at Intercontinental Hotels Group (IHG), Scottish and Newcastle plc and Care UK.
At Care UK this involved the entrepreneurial revenue and profit growth from a single site to 11 acute hospital facilities that deliver quality patient focused outcomes and financial sustainability. At IHG this involved the provision of improved customer experiences, brand appreciation and substantial financial returns at 43 UK hotels.
For the last 8 years Ian has operated in the not-for-profit sector with King Edward VII Hospital and Academies Enterprise Trust (70+ schools in the UK) and brings his broad and diverse commercial perspective in the management and investment of charitable funds and resources to Anthony Nolan.
His role is to take responsibility for the leadership of Anthony Nolan’s financial strategy, governance, financial control, treasury and risk management, legal and physical resources as well as playing a key role in new commercial developments. Ian is a strong advocate of the ‘value add’ principle with a passion for understanding and developing a charitable business.
Professor Antonio Pagliuca
Chief Medical and Scientific Adviser
Antonio Pagliuca was recently appointed as the Chief Medical and Scientific Adviser for the Anthony Nolan. He is also a Consultant Hematologist and Professor of Stem Cell Transplantation at King’s College Hospital and King’s College London
He is also a trustee for Leukaemia UK.
Past roles include President of BSBMT, Chair of the BMT CRG and National Clinical Lead for Regenerative Medicine, NHS England and most recently the Medical Director for King’s College Hospital, Networked Care Division.
As Transplant Director for 19 years to 2017, he lead King’s attainment to a Centre of Excellence and one of the largest unrelated, cord, haplo-identical transplant and cellular therapy programs in the UK. In 2018, King’s became the first CAR-T centre in the UK to treat both adult ALL and NHL. He has published widely on hematological malignancies, stem cell transplantation and infections in this patient group.